{"nct_id":"NCT00699166","title":"Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)","status":"COMPLETED","status_verified_date":"2008-06","start_date":"2004-04","start_date_type":null,"primary_completion_date":"2005-09","primary_completion_date_type":"ACTUAL","completion_date":"2005-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}